Cerus (CERS) Restructuring Costs (2010)
Cerus' (CERS) quarterly Restructuring Costs came in at -$182000.0 in Q4 2010, up 9.45% quarter-over-quarter from -$201000.0 in Q3 2010.
Analysis
Cerus (CERS) Restructuring Costs (2010) Analysis & Trends
Cerus has disclosed Restructuring Costs across 1 years of filings, most recently posting -$182000.0 for Q4 2010.
- In Q4 2010, Restructuring Costs changed N/A year-over-year to -$182000.0; the TTM figure through Dec 2011 stood at -$182000.0 (changed N/A YoY), while the FY2009 annual figure was $841000.0, changed N/A from the prior year.
- Restructuring Costs came in at -$182000.0 for Q4 2010 at Cerus, up from -$201000.0 in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $132000.0 in Q2 2010 to a low of -$201000.0 in Q3 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Cerus | 504.42 Mn | 448.16 Mn | 29.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2010 | -182,000.00 |
| Sep 30, 2010 | -201,000.00 |
| Jun 30, 2010 | 132,000.00 |